Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics

Aminoglycosides are widely used to treat infections of Pseudomonas aeruginosa. Genes encoding aminoglycoside-modifying enzymes (AMEs), acquired by horizontal gene transfer, are commonly associated with aminoglycoside resistance, but their effects have not been quantified. The aim of this research wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Thacharodi, Aswin, Lamont, Iain L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312099/
https://www.ncbi.nlm.nih.gov/pubmed/35884138
http://dx.doi.org/10.3390/antibiotics11070884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312099/
https://www.ncbi.nlm.nih.gov/pubmed/35884138
http://dx.doi.org/10.3390/antibiotics11070884

Ejemplares similares